Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030

icon1
USD 85.09 BN
MARKET SIZE, 2030
icon2
CAGR 12.6%
(2025-2030)
icon3
560
REPORT PAGES
icon4
671
MARKET TABLES

OVERVIEW

genomics-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, registering a CAGR of 12.6% from 2025 to 2030. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics.

KEY TAKEAWAYS

  • BY REGION
    In 2024, North America accounted for the largest share of 40.9% of the genomics market. The development of personalized medicine, the presence of key players in the market, and the increasing incidence of chronic diseases are some factors supporting the growth of the North American genomics market.
  • BY OFFERING
    By offering, the products segment accounted for the largest share of 74% of the genomics market in 2024. This dominance can primarily be attributed to the growing focus of researchers on genome sequencing projects and the increased demand for genomic products in the market.
  • BY TECHNOLOGY
    By technology, the sequencing segment is expected to register the highest CAGR of the genomic products market, due to its vital role in advancements in genetic research, diagnostics, and personalized medicine. Sequencing technologies, such as next-generation sequencing (NGS) and long-read sequencing, have transformed our ability to decode entire genomes. These technologies provide unmatched speed, accuracy, and depth of analysis.
  • BY APPLICATION
    By application, the drug discovery & development segment dominates the genomics market with a share of 44.8%. The large share is due to the growing demand for personalized therapeutics, as genomics-driven drug discovery continues to gain traction, reinforcing its substantial share in the application segment.
  • COMPETITIVE LANDSCAPE
    Illumina, Inc., Thermo Fisher Scientific Inc., and Danaher Corporation were identified as Star players in the genomics market, as they have focused on innovation and have broad industry coverage and strong operational & financial strength. Creative Biogene, Novogene Co., Ltd., and Helix, Inc. have distinguished themselves among startups and SMEs due to their strong product portfolio and business strategy.

The genomics market is experiencing steady growth, driven by advancements in next-generation sequencing (NGS) and the expanding applications of precision medicine and diagnostics. Additionally, there is an increasing amount of government and private funding for genomic research. The rising prevalence of genetic and chronic diseases, along with the integration of artificial intelligence (AI) and bioinformatics for data interpretation, is further driving market adoption across research, clinical, and pharmaceutical sectors.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The genomics market is being transformed by rapid technological advancements, including AI-driven data analysis, cloud-based bioinformatics, and automated sequencing workflows. Emerging trends, such as long-read sequencing, single-cell sequencing, and multi-omics integration, are improving data accuracy and providing deeper biological insights. As a result, pharmaceutical and biotech companies, along with research organizations, are increasingly adopting data-centric and scalable genomic solutions to enhance efficiency, drive innovation, and improve clinical outcomes.

genomics-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing government funding for genomics projects
  • Increasing prevalence of viral and inherited disorders
RESTRAINTS
Impact
Level
  • High investments
OPPORTUNITIES
Impact
Level
  • Increasing use of genomics in precision medicine
  • Technological advancements in genomics
CHALLENGES
Impact
Level
  • Handling of large volumes of data sets and their analysis
  • Clinical utility of genomics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing prevalence of viral and inherited disorders

The increasing prevalence of viral and inherited disorders is a major factor driving the growth of the genomics market. Genomic technologies, such as next-generation sequencing (NGS) and long-read sequencing, can quickly and accurately identify genetic mutations and viral pathogens. This capability aids in the early diagnosis and management of conditions like cystic fibrosis and sickle-cell anemia, among others. Furthermore, identifying mutations at the molecular level for targeted therapies has led to a heightened demand for genomics-based diagnostic tools.

Restraint: High investments

The implementation of advanced technologies, such as next-generation sequencing, long-read sequencing, and gene-editing tools like CRISPR, requires substantial capital investment, which can pose significant constraints. Establishing a genomics facility demands high capital expenditures for specialized instruments, reagents, and bioinformatics infrastructure. Many sequencing platforms and most high-throughput instruments are capital-intensive, resulting in substantial long-term operational costs for maintenance, calibration, and upgrades. These high costs can make it prohibitively expensive for smaller research institutions, healthcare facilities, and companies, thereby limiting widespread adoption of these technologies.

Opportunity: Increasing use of genomics in precision medicine

The increasing use of genomics in precision medicine represents a significant growth opportunity in the genomics market. Precision medicine tailors medical treatment to the individual characteristics of each patient and relies heavily on genomics to analyze genetic variations that influence patients' risks, disease progressions, and treatment responses. By utilizing data from genomics, therapy can be personalized, resulting in improved patient outcomes and reduced reliance on traditional treatments that can be hit-or-miss. The most prominent applications of this approach are found in oncology, where genomics is used to identify cancer-causing mutations that inform targeted therapy selection.

Challenge: Handling of large volumes of data sets and their analysis

One of the main challenges in handling large-scale data volumes and their analysis significantly impacts the genomics market. Next-generation sequencing (NGS) and similar technologies used in genomic applications can generate hundreds of gigabytes to several terabytes of data in just one experiment, particularly in large projects such as whole-genome sequencing and population genomics. The sheer volume of generated data creates issues with storage, processing, and interpretation, necessitating substantial computational infrastructure and specialized bioinformatics tools. As a result, there is a growing demand for high-performance computing (HPC) systems that can efficiently manage and process these large datasets.

genomics-market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Nationwide clinical whole-genome sequencing for rare disease and cancer via the 100,000 Genomes Project, running an end-to-end pipeline, from hospital sampling through analysis, using Illumina high-throughput sequencers for data generation. 18.5% of participants’ data produced actionable findings | Foundation for NHS Genomic Medicine Service
Adoption of Illumina DRAGEN secondary analysis in the hospital’s clinical genomics pipeline. Faster secondary analysis and streamlined clinical reporting from DRAGEN’s accelerated variant calling | Improved efficiency for hospital genomics workflows
Used QIAGEN Ingenuity Pathway Analysis (IPA) to mine multi-omics data and identify a novel biomarker that predicts which ovarian cancer patients are likely to respond to standard chemotherapy. Enabled patient stratification and response prediction, informing treatment decisions | Accelerated discovery by leveraging IPA’s curated pathways/knowledge base

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem analysis of the genomics market provides a thorough understanding of the interconnected network of stakeholders, resources, and interactions that shape the industry's dynamics. This ecosystem includes a variety of entities involved in the development, manufacturing, distribution, and utilization of genomics technologies. Key participants include technology developers, suppliers of consumables, service providers, and end users such as research institutions, clinical laboratories, and biotechnology companies. Additionally, regulatory authorities and standards organizations play crucial roles in influencing market trends, driving innovation, and ensuring the ethical use of genomic data.

genomics-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

genomics-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Genomic Products Market, By Type

In 2024, the reagents, kits, and consumables segment held the largest share of the genomics products market, owing to their essential role in sample preparation, library construction, amplification, and sequencing. These products are critical for generating accurate and reproducible genomic data and are required on a recurring basis in both research and diagnostics. The increasing use of NGS and PCR applications, combined with the growth of genomics research and clinical applications, continues to create a strong demand for high-quality reagents and consumables.

Genomic Products Market, By Technology

In 2024, the sequencing segment held the largest share of the genomic products market. This dominance is driven by continuous advances in next-generation sequencing (NGS) technologies, which offer high accuracy, scalability, and cost efficiency. Growing applications in precision medicine, biomarker discovery, and clinical diagnostics, along with the integration of AI-driven data analysis, further drive its widespread adoption and market leadership.

Genomic Products Market, By End User

In 2024, the hospitals, diagnostic laboratories, and clinics segment accounted for the largest share of the genomics products market. This can be attributed to the shift from traditional genomic testing methods to cost-effective and more sensitive techniques, such as whole-exome sequencing. Moreover, a wide range of applications, including genetic research, clinical diagnostics, and personalized medicine, drive the segment growth.

Genomic Services Market, By Type

In 2024, the genomic profiling and sequencing services segment held the largest share of the genomic services market. This dominance is driven by continuous advancements in next-generation sequencing (NGS), long-read sequencing, and other high-throughput platforms that have significantly enhanced sequencing speed, accuracy, and cost efficiency. These technological improvements have expanded the accessibility of sequencing services, facilitating their widespread adoption across both research and clinical applications.

Genomics Market, By Study Type

The functional genomics segment accounted for the largest share of the genomics market in 2024. This dominance is driven by its critical role in drug discovery, personalized medicine, and disease mechanism research. The increasing emphasis on translating genomic information into therapeutic insights and identifying gene functions and interactions has further elevated the importance of functional genomics. As research continues to shift toward precision and targeted therapies, demand for functional genomics is expected to rise steadily across both academic and clinical settings.

Genomics Market, By Application

The Diagnostic segment is expected to grow at the fastest rate during the forecast period in the genomics market. In diagnostics, genomics helps identify chromosomal disorders, dysmorphic syndromes, teratogenic disorders, and single-gene disorders. The use of genomics in diagnostics is expected to grow as new applications are added.

REGION

Asia Pacific to be fastest-growing region in global genomics market during forecast period

The Asia Pacific genomics market is expected to register the highest CAGR during the forecast period, driven by rising investments in life science research, expanding healthcare infrastructures, and the growing adoption of precision medicine across key countries such as China, Japan, and India. Government initiatives supporting national genome projects, coupled with increasing collaborations between global and regional players, are accelerating technology transfer and local innovation. Additionally, a large patient base for genetic and chronic diseases is further fueling the demand for genomics-based diagnostics and research in the region.

genomics-market Region

genomics-market: COMPANY EVALUATION MATRIX

In the genomics market matrix, Thermo Fisher Scientific Inc. (Star) leads with a strong market share and a comprehensive product portfolio that spans sequencing platforms, consumables, reagents, and analytical tools. Its broad global presence, continuous product innovation, and strategic collaborations have strengthened its leadership in enabling advanced genomic research and clinical applications. Oxford Nanopore Technologies Plc. (Emerging Leader) is gaining prominence through its novel nanopore sequencing technology, offering scalable and real-time genomic analysis solutions. Oxford Nanopore Technologies shows strong potential to move toward the leaders’ quadrant as the adoption of portable and rapid sequencing platforms continues to accelerate globally.

genomics-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 44.52 Billion
Market Forecast in 2030 (Value) USD 85.09 Billion
Growth Rate CAGR of 12.6% from 2025–2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offering:
    • Products
    • Services
  • Products by Type:
    • Reagents
    • Kits
    • and Consumables; Instruments; Bioinformatics Tools
  • Products by Technology:
    • Sequencing
    • PCR
    • Gene Editing
    • Flow Cytometry
    • Microarrays
    • In Situ Hybridization
    • Other Technologies
  • Products by End User:
    • Hospitals
    • Diagnostic Laboratories
    • and Clinics; Academic & Research Institutes; Pharmaceutical & Biotechnology Companies; CROs
    • Other End Users
  • Services by Type:
    • Genomic Profiling and Sequencing Services
    • Sample Preparation and Library Preparation Services
    • Bioinformatics Service
  • Application:
    • Drug Discovery & Development
    • Diagnostics
    • Agriculture and Animal Research
    • Other Applications
  • Study Type:
    • Functional Genomics
    • Biomarker Discovery
    • Pathway Analysis
    • Epigenomics
    • Other Study Types
  • End User by Services:
    • Hospitals
    • Diagnostic Laboratories
    • and Clinics
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

WHAT IS IN IT FOR YOU: genomics-market REPORT CONTENT GUIDE

genomics-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Europe Genomics Market
  • Country-level market estimation & forecast of the European genomics market
  • Market growth trends analysis
  • Detailed company profiles of competitors
  • Enables prioritized market entry/expansion
  • Helps to anticipate demand
South Korea Gene Editing Market The diagnostics segment is expected to grow at the fastest rate during the forecast period in the genomics market. In diagnostics, genomics helps identify chromosomal disorders, dysmorphic syndromes, teratogenic disorders, and single-gene disorders. The use of genomics in diagnostics is expected to grow as new applications are added Supports localization strategy, partnership development, and identification of high-growth segments in South Korea

RECENT DEVELOPMENTS

  • October 2025 : 10x Genomics, Inc. launched the next generation of its Flex assay, designed for automation-compatible, plate-based multiplexing. The new assay enables scalable single-cell analysis for applications such as functional genomics, CRISPR screens, and FFPE-based translational studies.
  • May 2025 : QIAGEN signed a definitive agreement to acquire Genoox, an AI-driven software provider supporting large-scale genetic test analysis. The acquisition adds Genoox’s cloud-based Franklin platform to the QIAGEN Digital Insights portfolio, enhancing its capabilities in clinical genomics data interpretation.
  • February 2025 : Roche introduced its proprietary Sequencing by Expansion (SBX) technology, a novel approach in next-generation sequencing. The SBX chemistry, integrated with an advanced sensor module, enables ultra-rapid, high-throughput sequencing with enhanced flexibility and scalability across diverse applications.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
44
2
RESEARCH METHODOLOGY
 
 
 
 
 
49
3
EXECUTIVE SUMMARY
 
 
 
 
 
63
4
PREMIUM INSIGHTS
 
 
 
 
 
71
5
MARKET OVERVIEW
Explore genomics' transformative potential as funding, technology, and precision medicine drive market evolution.
 
 
 
 
 
74
 
5.1
INTRODUCTION
 
 
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
 
 
5.2.1.1
INCREASING GOVERNMENT FUNDING FOR GENOMICS PROJECTS
 
 
 
 
 
 
5.2.1.2
INCREASING PREVALENCE OF VIRAL AND INHERITED DISORDERS
 
 
 
 
 
 
5.2.1.3
ADVANCEMENTS IN NGS PLATFORMS
 
 
 
 
 
 
5.2.1.4
GROWING APPLICATIONS OF GENOMICS
 
 
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
 
 
5.2.2.1
HIGH INVESTMENT COSTS
 
 
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
5.2.3.1
INCREASING USE OF GENOMICS IN PRECISION MEDICINE
 
 
 
 
 
 
5.2.3.2
TECHNOLOGICAL ADVANCEMENTS IN GENOMICS
 
 
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
 
 
5.2.4.1
HANDLING LARGE VOLUMES OF DATA SETS AND THEIR ANALYSIS
 
 
 
 
 
 
5.2.4.2
CLINICAL UTILITY OF GENOMICS
 
 
 
 
5.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
5.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
5.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
6
INDUSTRY TRENDS
Uncover strategic shifts in genomics with competitive dynamics and pricing trends shaping the future.
 
 
 
 
 
84
 
6.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
6.1.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
 
6.1.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
6.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
6.1.4
THREAT OF SUBSTITUTES
 
 
 
 
 
 
6.1.5
THREAT OF NEW ENTRANTS
 
 
 
 
 
6.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
6.2.1
INTRODUCTION
 
 
 
 
 
 
6.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
6.2.3
TRENDS IN GLOBAL GENOMICS INDUSTRY
 
 
 
 
 
6.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
6.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
6.4.1
EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS
 
 
 
 
 
6.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
6.5.1
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022–2024
 
 
 
 
 
 
6.5.2
AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022–2024
 
 
 
 
 
 
6.5.3
AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024
 
 
 
 
 
 
6.5.4
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022–2024
 
 
 
 
 
6.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
6.6.1
IMPORT SCENARIO (HS CODE 3822 & 902789)
 
 
 
 
 
 
6.6.2
EXPORT SCENARIO (HS CODE 3822 & 902789)
 
 
 
 
 
6.7
KEY CONFERENCES AND EVENTS, 2026
 
 
 
 
 
 
6.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
6.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
 
6.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
 
 
 
 
 
6.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
6.11
IMPACT OF 2025 US TARIFFS—GENOMICS MARKET
 
 
 
 
 
 
 
 
6.11.1
INTRODUCTION
 
 
 
 
 
 
6.11.2
KEY TARIFF RATES
 
 
 
 
 
 
6.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
6.11.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
6.11.4.1
US
 
 
 
 
 
 
6.11.4.2
EUROPE
 
 
 
 
 
 
6.11.4.3
ASIA PACIFIC
 
 
 
 
 
6.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
6.11.5.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
6.11.5.2
CROS AND ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
6.11.5.3
HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
 
 
 
7
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
AI and emerging tech revolutionize genomics, driving innovation and patent growth.
 
 
 
 
 
112
 
7.1
TECHNOLOGICAL ANALYSIS
 
 
 
 
 
 
 
7.1.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
7.1.1.1
SEQUENCING BY SYNTHESIS
 
 
 
 
 
 
7.1.1.2
SINGLE-MOLECULE REAL-TIME SEQUENCING
 
 
 
 
 
 
7.1.1.3
NANOPORE SEQUENCING
 
 
 
 
 
 
7.1.1.4
QPCR
 
 
 
 
 
 
7.1.1.5
DPCR
 
 
 
 
 
 
7.1.1.6
MICROARRAY TECHNOLOGY
 
 
 
 
 
7.1.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
7.1.2.1
CYTOGENETICS
 
 
 
 
 
 
7.1.2.2
SYNTHETIC BIOLOGY
 
 
 
 
 
 
7.1.2.3
MULTIOMICS
 
 
 
 
 
 
7.1.2.4
SINGLE-CELL ANALYSIS
 
 
 
 
 
7.1.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
7.1.3.1
BIOINFORMATICS AND COMPUTATIONAL BIOLOGY
 
 
 
 
 
 
7.1.3.2
ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
 
 
 
 
7.2
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
7.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
7.3.1
TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014–2024
 
 
 
 
 
7.4
FUTURE APPLICATIONS
 
 
 
 
 
 
7.5
IMPACT OF AI/GEN AI ON GENOMICS MARKET
 
 
 
 
 
 
 
 
7.5.1
BEST PRACTICES IN GENOMICS WORKFLOW
 
 
 
 
 
 
7.5.2
CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET
 
 
 
 
 
 
7.5.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
7.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN GENOMICS MARKET
 
 
 
 
8
SUSTAINABILITY AND REGULATORY LANDSCAPE
Navigate complex global regulations with insights on sustainability initiatives and compliance standards.
 
 
 
 
 
125
 
8.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
8.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
8.1.2
INDUSTRY STANDARDS
 
 
 
 
 
8.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
8.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
 
 
8.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
 
 
9
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock strategic advantages by understanding stakeholder influence and unmet needs in buyer decisions.
 
 
 
 
 
132
 
9.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
9.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
9.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
9.2.2
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
9.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
9.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
9.5
MARKET PROFITABILITY
 
 
 
 
 
10
GENOMICS MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 15 Data Tables
 
 
 
 
 
136
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
PRODUCTS
 
 
 
 
 
 
 
10.2.1
ACCELERATION OF HIGH-THROUGHPUT GENOMICS DRIVEN BY PLATFORM INNOVATION AND AUTOMATION IS BOOSTING GROWTH
 
 
 
 
 
10.3
SERVICES
 
 
 
 
 
 
 
10.3.1
RAPID EXPANSION OF GENOMIC SERVICES FUELED BY CLINICAL ADOPTION AND DATA-DRIVEN DECISION SUPPORT
 
 
 
 
11
GENOMICS PRODUCTS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables
 
 
 
 
 
144
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
REAGENTS, KITS, AND CONSUMABLES
 
 
 
 
 
 
 
11.2.1
LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE PROPEL DEMAND FOR REAGENTS, KITS, AND CONSUMABLES
 
 
 
 
 
11.3
INSTRUMENTS
 
 
 
 
 
 
 
11.3.1
TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.4
BIOINFORMATICS TOOLS
 
 
 
 
 
 
 
11.4.1
ACCELERATING GENOMIC INSIGHTS THROUGH SCALABLE, AI-ENABLED BIOINFORMATICS PLATFORMS DRIVE MARKET GROWTH
 
 
 
 
12
GENOMICS PRODUCTS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 52 Data Tables
 
 
 
 
 
158
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
SEQUENCING
 
 
 
 
 
 
 
12.2.1
DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH
 
 
 
 
 
12.3
PCR
 
 
 
 
 
 
 
12.3.1
RISING DEMAND FOR BIOMARKER DISCOVERY TO PROPEL MARKET GROWTH
 
 
 
 
 
12.4
GENE EDITING
 
 
 
 
 
 
 
12.4.1
RISING DEMAND FOR NEWER THERAPEUTIC APPROACHES DRIVING GROWTH
 
 
 
 
 
12.5
FLOW CYTOMETRY
 
 
 
 
 
 
 
12.5.1
RISING DEMAND FOR FLOW CYTOMETRY IN AGRIGENOMICS TO DRIVE MARKET GROWTH
 
 
 
 
 
12.6
MICROARRAYS
 
 
 
 
 
 
 
12.6.1
RISING ADOPTION OF HIGH-THROUGHPUT TECHNOLOGIES LIMITING MARKET GROWTH
 
 
 
 
 
12.7
IN SITU HYBRIDIZATION
 
 
 
 
 
 
 
12.7.1
INCREASING DEMAND FOR PRECISE GENE EXPRESSION ANALYSIS DRIVING GROWTH
 
 
 
 
 
12.8
OTHER TECHNOLOGIES
 
 
 
 
 
13
GENOMICS PRODUCTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 36 Data Tables
 
 
 
 
 
186
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
 
 
 
 
 
 
 
13.2.1
INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
 
 
 
 
 
13.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
13.3.1
RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
 
 
 
 
 
13.4
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
13.4.1
RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS PROPELS MARKET
 
 
 
 
 
13.5
CROS
 
 
 
 
 
 
 
13.5.1
RISING COLLABORATION BETWEEN PHARMA COMPANIES AND CROS DRIVING MARKET GROWTH
 
 
 
 
 
13.6
OTHER END USERS
 
 
 
 
 
14
GENOMICS SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables
 
 
 
 
 
207
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
GENOMIC PROFILING & SEQUENCING SERVICES
 
 
 
 
 
 
 
14.2.1
INCREASED ADOPTION OF SEQUENCING TECHNOLOGIES IN CLINICAL ADOPTION TO SUPPORT MARKET GROWTH
 
 
 
 
 
14.3
SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES
 
 
 
 
 
 
 
14.3.1
INCREASED DEMAND FOR ONCOLOGY AND RARE DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH
 
 
 
 
 
14.4
BIOINFORMATICS SERVICES
 
 
 
 
 
 
 
14.4.1
RISING DEMAND FOR ADVANCED PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
 
 
 
 
15
GENOMICS SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 29 Data Tables
 
 
 
 
 
219
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
 
 
 
 
 
 
 
15.2.1
INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
 
 
 
 
 
15.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
15.3.1
RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
 
 
 
 
 
15.4
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
15.4.1
RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO DRIVE GROWTH
 
 
 
 
 
15.5
OTHER END USERS
 
 
 
 
 
16
GENOMICS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 59 Data Tables
 
 
 
 
 
235
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
 
 
16.2.1
DRUG DISCOVERY & DEVELOPMENT TO BE LARGEST APPLICATION IN GENOMICS MARKET
 
 
 
 
 
16.3
DIAGNOSTICS
 
 
 
 
 
 
 
16.3.1
CANCER DIAGNOSTICS
 
 
 
 
 
 
 
16.3.1.1
RISING DEMAND FOR TARGETED THERAPIES TO DRIVE MARKET GROWTH
 
 
 
 
 
16.3.2
INFECTIOUS DISEASES
 
 
 
 
 
 
 
16.3.2.1
RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO DRIVE MARKET GROWTH
 
 
 
 
 
16.3.3
REPRODUCTIVE HEALTH
 
 
 
 
 
 
 
16.3.3.1
RISING FOCUS ON GENETIC DISEASES TO DRIVE MARKET GROWTH
 
 
 
 
 
16.3.4
OTHER DIAGNOSTIC APPLICATIONS
 
 
 
 
 
16.4
AGRICULTURE & ANIMAL RESEARCH
 
 
 
 
 
 
 
16.4.1
GENOMICS TO HELP IMPROVE CROP PRODUCTIVITY
 
 
 
 
 
16.5
OTHER APPLICATIONS
 
 
 
 
 
17
GENOMICS MARKET, BY STUDY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 36 Data Tables
 
 
 
 
 
265
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
FUNCTIONAL GENOMICS
 
 
 
 
 
 
 
17.2.1
INCREASED FOCUS ON FUNCTIONAL GENOME STUDIES TO DRIVE MARKET GROWTH
 
 
 
 
 
17.3
BIOMARKER DISCOVERY
 
 
 
 
 
 
 
17.3.1
RISING DEMAND FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH
 
 
 
 
 
17.4
PATHWAY ANALYSIS
 
 
 
 
 
 
 
17.4.1
RISING PREVALENCE OF COMPLEX DISEASES TO AUGMENT MARKET GROWTH
 
 
 
 
 
17.5
EPIGENOMICS
 
 
 
 
 
 
 
17.5.1
RISING INVESTMENTS FOR EPIGENETICS RESEARCH TO BOOST MARKET GROWTH
 
 
 
 
 
17.6
OTHER STUDY TYPES
 
 
 
 
 
18
GENOMICS MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 17 Countries | 265 Data Tables.
 
 
 
 
 
285
 
18.1
INTRODUCTION
 
 
 
 
 
 
18.2
NORTH AMERICA
 
 
 
 
 
 
 
18.2.1
NORTH AMERICA: MACROECONOMIC OUTLOOK
 
 
 
 
 
 
18.2.2
US
 
 
 
 
 
 
 
18.2.2.1
US EXPECTED TO DOMINATE MARKET IN NORTH AMERICA
 
 
 
 
 
18.2.3
CANADA
 
 
 
 
 
 
 
18.2.3.1
INCREASING GOVERNMENT INITIATIVES IN GENOMICS RESEARCH TO BOOST MARKET GROWTH
 
 
 
 
18.3
EUROPE
 
 
 
 
 
 
 
18.3.1
EUROPE: MACROECONOMIC OUTLOOK
 
 
 
 
 
 
18.3.2
GERMANY
 
 
 
 
 
 
 
18.3.2.1
GERMANY TO DOMINATE EUROPEAN GENOMICS MARKET
 
 
 
 
 
18.3.3
UK
 
 
 
 
 
 
 
18.3.3.1
STRATEGIC INITIATIVES AND FUNDING FOR GENOMICS RESEARCH TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.3.4
FRANCE
 
 
 
 
 
 
 
18.3.4.1
INCREASING GOVERNMENT INVESTMENT IN GENOMICS RESEARCH TO DRIVE GROWTH
 
 
 
 
 
18.3.5
ITALY
 
 
 
 
 
 
 
18.3.5.1
FAVORABLE FUNDING SCENARIO TO DRIVE ADOPTION OF ADVANCED SEQUENCING TECHNOLOGY
 
 
 
 
 
18.3.6
SPAIN
 
 
 
 
 
 
 
18.3.6.1
GROWING FOCUS ON ADVANCEMENTS IN PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.3.7
REST OF EUROPE
 
 
 
 
 
18.4
ASIA PACIFIC
 
 
 
 
 
 
 
18.4.1
ASIA PACIFIC: MACROECONOMIC OUTLOOK
 
 
 
 
 
 
18.4.2
CHINA
 
 
 
 
 
 
 
18.4.2.1
CHINA TO DOMINATE ASIA PACIFIC MARKET DURING FORECAST PERIOD
 
 
 
 
 
18.4.3
JAPAN
 
 
 
 
 
 
 
18.4.3.1
RISING NUMBER OF COLLABORATIONS IN GENOMICS TO DRIVE MARKET
 
 
 
 
 
18.4.4
INDIA
 
 
 
 
 
 
 
18.4.4.1
GOVERNMENT AND PRIVATE INITIATIVES FOR GENOMICS TO PROPEL MARKET
 
 
 
 
 
18.4.5
AUSTRALIA
 
 
 
 
 
 
 
18.4.5.1
INCREASED GENOMICS RESEARCH IN AUSTRALIA TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.4.6
SOUTH KOREA
 
 
 
 
 
 
 
18.4.6.1
DEMAND FOR ADVANCED SEQUENCING TECHNOLOGIES TO SUPPORT MARKET GROWTH IN SOUTH KOREA
 
 
 
 
 
18.4.7
REST OF ASIA PACIFIC
 
 
 
 
 
18.5
LATIN AMERICA
 
 
 
 
 
 
 
18.5.1
LATIN AMERICA: MACROECONOMIC OUTLOOK
 
 
 
 
 
 
18.5.2
BRAZIL
 
 
 
 
 
 
 
18.5.2.1
INCREASED GOVERNMENT INVESTMENTS IN GENOMICS ADVANCEMENTS TO DRIVE MARKET IN BRAZIL
 
 
 
 
 
18.5.3
MEXICO
 
 
 
 
 
 
 
18.5.3.1
RISING DEMAND FOR CHRONIC DISEASE TREATMENT TO SUPPORT MARKET GROWTH IN MEXICO
 
 
 
 
 
18.5.4
REST OF LATIN AMERICA
 
 
 
 
 
18.6
MIDDLE EAST
 
 
 
 
 
 
 
18.6.1
MIDDLE EAST: MACROECONOMIC OUTLOOK
 
 
 
 
 
 
18.6.2
GCC COUNTRIES
 
 
 
 
 
 
 
18.6.2.1
SAUDI ARABIA
 
 
 
 
 
 
 
 
18.6.2.1.1
GROWING HEALTHCARE EXPENDITURE IN SAUDI ARABIA TO BOOST MARKET GROWTH
 
 
 
 
18.6.2.2
UNITED ARAB EMIRATES
 
 
 
 
 
 
 
 
18.6.2.2.1
GROWING COLLABORATIONS TO ADVANCE GENOME SEQUENCING TO AID MARKET GROWTH IN UAE
 
 
 
 
18.6.2.3
REST OF GCC COUNTRIES
 
 
 
 
 
18.6.3
REST OF MIDDLE EAST
 
 
 
 
 
18.7
AFRICA
 
 
 
 
 
 
 
18.7.1
GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET IN AFRICA
 
 
 
 
 
 
18.7.2
AFRICA: MACROECONOMIC OUTLOOK
 
 
 
 
19
COMPETITIVE LANDSCAPE
Discover strategic moves and market positions shaping the genomics industry's competitive landscape.
 
 
 
 
 
424
 
19.1
INTRODUCTION
 
 
 
 
 
 
19.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
19.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GENOMICS MARKET
 
 
 
 
 
19.3
REVENUE ANALYSIS, 2020–2024
 
 
 
 
 
 
 
19.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
 
 
19.5
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
19.6
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
 
 
19.6.1
STARS
 
 
 
 
 
 
19.6.2
EMERGING LEADERS
 
 
 
 
 
 
19.6.3
PERVASIVE PLAYERS
 
 
 
 
 
 
19.6.4
PARTICIPANTS
 
 
 
 
 
 
19.6.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
 
 
19.6.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
19.6.5.2
REGION FOOTPRINT
 
 
 
 
 
 
19.6.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
 
19.6.5.4
APPLICATION FOOTPRINT
 
 
 
 
 
 
19.6.5.5
TECHNOLOGY FOOTPRINT
 
 
 
 
19.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
 
 
19.7.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
19.7.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
19.7.3
DYNAMIC COMPANIES
 
 
 
 
 
 
19.7.4
STARTING BLOCKS
 
 
 
 
 
 
19.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
 
 
19.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
19.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
19.8
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
19.8.1
FINANCIAL METRICS
 
 
 
 
 
 
19.8.2
COMPANY VALUATION
 
 
 
 
 
19.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
19.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
19.9.2
DEALS
 
 
 
 
 
 
19.9.3
EXPANSIONS
 
 
 
 
20
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
445
 
20.1
INTRODUCTION
 
 
 
 
 
 
20.2
KEY PLAYERS
 
 
 
 
 
 
 
20.2.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
 
20.2.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
20.2.1.2
PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
20.2.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
20.2.1.3.1
PRODUCT LAUNCHES AND APPROVALS
 
 
 
 
 
 
20.2.1.3.2
DEALS
 
 
 
 
 
 
20.2.1.3.3
EXPANSIONS
 
 
 
 
20.2.1.4
MNM VIEW
 
 
 
 
 
 
 
 
20.2.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
20.2.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
20.2.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
20.2.2
ILLUMINA, INC.
 
 
 
 
 
 
20.2.3
DANAHER CORPORATION
 
 
 
 
 
 
20.2.4
F. HOFFMANN-LA ROCHE LTD.
 
 
 
 
 
 
20.2.5
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
20.2.6
QIAGEN
 
 
 
 
 
 
20.2.7
REVVITY
 
 
 
 
 
 
20.2.8
LABORATORY CORPORATION OF AMERICA HOLDINGS
 
 
 
 
 
 
20.2.9
IQVIA INC.
 
 
 
 
 
 
20.2.10
CHARLES RIVER LABORATORIES
 
 
 
 
 
 
20.2.11
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
 
20.2.12
EUROFINS SCIENTIFIC
 
 
 
 
 
 
20.2.13
PACBIO
 
 
 
 
 
 
20.2.14
OXFORD NANOPORE TECHNOLOGIES PLC.
 
 
 
 
 
 
20.2.15
TAKARA BIO INC.
 
 
 
 
 
 
20.2.16
BGI GROUP
 
 
 
 
 
 
20.2.17
EPPENDORF SE
 
 
 
 
 
 
20.2.18
MERCK KGAA
 
 
 
 
 
 
20.2.19
BD
 
 
 
 
 
 
20.2.20
ABBOTT
 
 
 
 
 
 
20.2.21
10X GENOMICS
 
 
 
 
 
 
20.2.22
NEW ENGLAND BIOLABS
 
 
 
 
 
 
20.2.23
PROMEGA CORPORATION
 
 
 
 
 
20.3
OTHER PLAYERS
 
 
 
 
 
 
 
20.3.1
CREATIVE BIOGENE
 
 
 
 
 
 
20.3.2
NOVOGENE CO., LTD.
 
 
 
 
 
 
20.3.3
HELIX, INC.
 
 
 
 
 
 
20.3.4
PHALANX BIOTECH GROUP
 
 
 
 
 
 
20.3.5
POLARIS GENOMICS
 
 
 
 
21
APPENDIX
 
 
 
 
 
579
 
21.1
DISCUSSION GUIDE
 
 
 
 
 
 
21.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
21.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
21.4
RELATED REPORTS
 
 
 
 
 
 
21.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
GENOMICS MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
 
 
TABLE 2
IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
TABLE 3
GENOMICS MARKET: RISK ANALYSIS
 
 
 
 
 
 
TABLE 4
GENOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
 
 
 
 
 
 
TABLE 5
GENOMICS MARKET: IMPACT OF PORTER’S FIVE FORCES
 
 
 
 
 
 
TABLE 6
GENOMICS MARKET: ROLE IN ECOSYSTEM
 
 
 
 
 
 
TABLE 7
GENOMICS MARKET: EMERGING BUSINESS MODELS & TARGET SEGMENTS
 
 
 
 
 
 
TABLE 8
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022–2024 (USD)
 
 
 
 
 
 
TABLE 9
AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022–2024 (USD)
 
 
 
 
 
 
TABLE 10
AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD)
 
 
 
 
 
 
TABLE 11
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022–2024 (USD)
 
 
 
 
 
 
TABLE 12
IMPORT VALUE FOR HS CODE 3822, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
TABLE 13
IMPORT VOLUME FOR HS CODE 3822, 2020–2024 (TONS)
 
 
 
 
 
 
TABLE 14
IMPORT VALUE FOR HS CODE 902789, 2022–2024 (USD THOUSAND)
 
 
 
 
 
 
TABLE 15
IMPORT VOLUME FOR HS CODE 902789, 2022–2024 (UNITS)
 
 
 
 
 
 
TABLE 16
EXPORT VALUE FOR HS CODE 3822, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
 
 
TABLE 17
EXPORT VOLUME FOR HS CODE 3822, BY COUNTRY, 2019–2023 (TONS)
 
 
 
 
 
 
TABLE 18
EXPORT VALUE FOR HS CODE 902789, 2022–2024 (USD THOUSAND)
 
 
 
 
 
 
TABLE 19
EXPORT VOLUME FOR HS CODE 902789, 2022–2024 (UNITS)
 
 
 
 
 
 
TABLE 20
GENOMICS MARKET: KEY CONFERENCES AND EVENTS, 2026
 
 
 
 
 
 
TABLE 21
SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES
 
 
 
 
 
 
TABLE 22
LONG-READ WHOLE GENOME SEQUENCING WAS USED IN CHILDREN'S MERCY KANSAS CITY
 
 
 
 
 
 
TABLE 23
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 24
GENOMICS MARKET: INDICATIVE LIST OF PATENTS, 2025
 
 
 
 
 
 
TABLE 25
CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET
 
 
 
 
 
 
TABLE 26
CLIENT’S READINESS TO ADOPT GENERATIVE AI IN GENOMICS
 
 
 
 
 
 
TABLE 27
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 28
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 29
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 30
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 31
US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
 
 
 
 
 
 
TABLE 32
US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
 
 
 
 
 
 
TABLE 33
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
 
 
 
 
 
 
TABLE 34
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
TABLE 35
GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 36
GENOMICS PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 37
NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 38
EUROPE: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 39
ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 40
LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 41
MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 42
GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 43
GENOMICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 44
NORTH AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 45
EUROPE: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 46
ASIA PACIFIC: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 47
LATIN AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 48
MIDDLE EAST: GENOMICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 49
GCC COUNTRIES: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 50
GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 51
GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 52
NORTH AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 53
EUROPE: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 54
ASIA PACIFIC: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 55
LATIN AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 56
MIDDLE EAST: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 57
GCC COUNTRIES: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 58
GENOMICS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 59
NORTH AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 60
EUROPE: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 61
ASIA PACIFIC: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 62
LATIN AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 63
MIDDLE EAST: GENOMICS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 64
GCC COUNTRIES: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 65
GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 66
NORTH AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 67
EUROPE: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 68
ASIA PACIFIC: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 69
LATIN AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 70
MIDDLE EAST: GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 71
GCC COUNTRIES: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 72
GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 73
SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 74
NORTH AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 75
EUROPE: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 76
ASIA PACIFIC: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 77
LATIN AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 78
MIDDLE EAST: SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 79
GCC COUNTRIES: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 80
SEQUENCING PLATFORMS MARKET, BY TYPE, 2023–2030 (UNITS)
 
 
 
 
 
 
TABLE 81
PCR PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 82
NORTH AMERICA: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 83
EUROPE: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 84
ASIA PACIFIC: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 85
LATIN AMERICA: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 86
MIDDLE EAST: PCR PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 87
GCC COUNTRIES: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 88
GENE EDITING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 89
NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 90
EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 91
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 92
LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 93
MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 94
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 95
FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 96
NORTH AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 97
EUROPE: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 98
ASIA PACIFIC: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 99
LATIN AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 100
MIDDLE EAST: FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 101
GCC COUNTRIES: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 102
FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2023–2030 (UNITS)
 
 
 
 
 
 
TABLE 103
MICROARRAY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 104
NORTH AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 105
EUROPE: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 106
ASIA PACIFIC: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 107
LATIN AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 108
MIDDLE EAST: MICROARRAY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 109
GCC COUNTRIES: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 110
IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 111
NORTH AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 112
EUROPE: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 113
ASIA PACIFIC: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 114
LATIN AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 115
MIDDLE EAST: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 116
GCC COUNTRIES: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 117
GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 118
NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 119
EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 120
ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 121
LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 122
MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 123
GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 124
GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 125
GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 126
NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 127
EUROPE: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 128
ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 129
LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 130
MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 131
GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 132
GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 133
NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 134
EUROPE: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 135
ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 136
LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 137
MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 138
GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 139
GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 140
NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 141
EUROPE: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 142
ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 143
LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 144
MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 145
GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 146
GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 147
NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 148
EUROPE: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 149
ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 150
LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 151
MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 152
GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 153
GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 154
NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 155
EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 156
ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 157
LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 158
MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 159
GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 160
GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 161
GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 162
NORTH AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 163
EUROPE: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 164
ASIA PACIFIC: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 165
LATIN AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 166
MIDDLE EAST: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 167
GCC COUNTRIES: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 168
SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 169
NORTH AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 170
EUROPE: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 171
ASIA PACIFIC: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 172
LATIN AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 173
MIDDLE EAST: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 174
GCC COUNTRIES: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 175
BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 176
NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 177
EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 178
ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 179
LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 180
MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 181
GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 182
GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 183
GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 184
NORTH AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 185
EUROPE: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 186
ASIA PACIFIC: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 187
LATIN AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 188
MIDDLE EAST: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 189
GCC COUNTRIES: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 190
GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 191
NORTH AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 192
EUROPE: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 193
ASIA PACIFIC: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 194
LATIN AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 195
MIDDLE EAST: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 196
GCC COUNTRIES: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 197
GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 198
NORTH AMERICA: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 199
EUROPE: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 200
ASIA PACIFIC: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 201
LATIN AMERICA: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 202
MIDDLE EAST: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 203
GCC COUNTRIES: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 204
GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 205
NORTH AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 206
EUROPE: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 207
ASIA PACIFIC: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 208
LATIN AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 209
MIDDLE EAST: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 210
GCC COUNTRIES: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 211
GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 212
GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 213
NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 214
EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 215
ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 216
LATIN AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 217
MIDDLE EAST: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 218
GCC COUNTRIES: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 219
GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 220
NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 221
EUROPE: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 222
ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 223
LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 224
MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 225
GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 226
GENOMICS MARKET FOR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 227
GRANTS, BY CANCER TYPE (AS OF OCTOBER 2025)
 
 
 
 
 
 
TABLE 228
GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 229
NORTH AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 230
EUROPE: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 231
ASIA PACIFIC: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 232
LATIN AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 233
MIDDLE EAST: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 234
GCC COUNTRIES: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 235
GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 236
NORTH AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 237
EUROPE: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 238
ASIA PACIFIC: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 239
LATIN AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 240
MIDDLE EAST: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 241
GCC COUNTRIES: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 242
GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 243
NORTH AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 244
EUROPE: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 245
ASIA PACIFIC: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 246
LATIN AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 247
MIDDLE EAST: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 248
GCC COUNTRIES: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 249
GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 250
NORTH AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 251
EUROPE: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 252
ASIA PACIFIC: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 253
LATIN AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 254
MIDDLE EAST: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 255
GCC COUNTRIES: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 256
GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 257
NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 258
EUROPE: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 259
ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 260
LATIN AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 261
MIDDLE EAST: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 262
GCC COUNTRIES: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 263
GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 264
NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 265
EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 266
ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 267
LATIN AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 268
MIDDLE EAST: GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 269
GCC COUNTRIES: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 270
GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 271
GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 272
NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 273
EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 274
ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 275
LATIN AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 276
MIDDLE EAST: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 277
GCC COUNTRIES: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 278
GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 279
NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 280
EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 281
ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 282
LATIN AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 283
MIDDLE EAST: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 284
GCC COUNTRIES: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 285
GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 286
NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 287
EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 288
ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 289
LATIN AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 290
MIDDLE EAST: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 291
GCC COUNTRIES: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 292
GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 293
NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 294
EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 295
ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 296
LATIN AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 297
MIDDLE EAST: GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 298
GCC COUNTRIES: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 299
GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 300
NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 301
EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 302
ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 303
LATIN AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 304
MIDDLE EAST: GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 305
GCC COUNTRIES: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 306
GENOMICS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 307
NORTH AMERICA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 308
NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 309
NORTH AMERICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 310
NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 311
NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 312
NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 313
NORTH AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 314
NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 315
NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 316
NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 317
NORTH AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 318
US: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 319
US: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 320
US: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 321
US: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 322
US: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 323
US: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 324
US: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 325
US: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 326
US: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 327
CANADA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 328
CANADA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 329
CANADA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 330
CANADA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 331
CANADA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 332
CANADA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 333
CANADA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 334
CANADA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 335
CANADA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 336
EUROPE: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 337
EUROPE: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 338
EUROPE: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 339
EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 340
EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 341
EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 342
EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 343
EUROPE: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 344
EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 345
EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 346
EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 347
GERMANY: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 348
GERMANY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 349
GERMANY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 350
GERMANY: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 351
GERMANY: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 352
GERMANY: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 353
GERMANY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 354
GERMANY: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 355
GERMANY: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 356
UK: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 357
UK: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 358
UK: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 359
UK: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 360
UK: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 361
UK: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 362
UK: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 363
UK: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 364
UK: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 365
FRANCE: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 366
FRANCE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 367
FRANCE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 368
FRANCE: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 369
FRANCE: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 370
FRANCE: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 371
FRANCE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 372
FRANCE: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 373
FRANCE: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 374
ITALY: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 375
ITALY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 376
ITALY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 377
ITALY: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 378
ITALY: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 379
ITALY: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 380
ITALY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 381
ITALY: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 382
ITALY: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 383
SPAIN: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 384
SPAIN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 385
SPAIN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 386
SPAIN: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 387
SPAIN: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 388
SPAIN: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 389
SPAIN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 390
SPAIN: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 391
SPAIN: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 392
REST OF EUROPE: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 393
REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 394
REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 395
REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 396
REST OF EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 397
REST OF EUROPE: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 398
REST OF EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 399
REST OF EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 400
REST OF EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 401
ASIA PACIFIC: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 402
ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 403
ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 404
ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 405
ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 406
ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 407
ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 408
ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 409
ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 410
ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 411
ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 412
CHINA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 413
CHINA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 414
CHINA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 415
CHINA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 416
CHINA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 417
CHINA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 418
CHINA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 419
CHINA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 420
CHINA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 421
JAPAN: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 422
JAPAN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 423
JAPAN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 424
JAPAN: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 425
JAPAN: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 426
JAPAN: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 427
JAPAN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 428
JAPAN: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 429
JAPAN: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 430
INDIA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 431
INDIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 432
INDIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 433
INDIA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 434
INDIA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 435
INDIA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 436
INDIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 437
INDIA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 438
INDIA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 439
AUSTRALIA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 440
AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 441
AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 442
AUSTRALIA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 443
AUSTRALIA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 444
AUSTRALIA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 445
AUSTRALIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 446
AUSTRALIA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 447
AUSTRALIA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 448
SOUTH KOREA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 449
SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 450
SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 451
SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 452
SOUTH KOREA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 453
SOUTH KOREA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 454
SOUTH KOREA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 455
SOUTH KOREA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 456
SOUTH KOREA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 457
REST OF ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 458
REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 459
REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 460
REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 461
REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 462
REST OF ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 463
REST OF ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 464
REST OF ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 465
REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 466
LATIN AMERICA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 467
LATIN AMERICA: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 468
LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 469
LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 470
LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 471
LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 472
LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 473
LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 474
LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 475
LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 476
LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 477
BRAZIL: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 478
BRAZIL: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 479
BRAZIL: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 480
BRAZIL: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 481
BRAZIL: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 482
BRAZIL: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 483
BRAZIL: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 484
BRAZIL: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 485
BRAZIL: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 486
MEXICO: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 487
MEXICO: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 488
MEXICO: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 489
MEXICO: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 490
MEXICO: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 491
MEXICO: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 492
MEXICO: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 493
MEXICO: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 494
MEXICO: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 495
REST OF LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 496
REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 497
REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 498
REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 499
REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 500
REST OF LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 501
REST OF LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 502
REST OF LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 503
REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 504
MIDDLE EAST: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 505
MIDDLE EAST: GENOMICS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 506
MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 507
MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 508
MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 509
MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 510
MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 511
MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 512
MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 513
MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 514
MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 515
GCC COUNTRIES: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 516
GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 517
GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 518
GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 519
GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 520
GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 521
GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 522
GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 523
GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 524
GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 525
SAUDI ARABIA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 526
SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 527
SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 528
SAUDI ARABIA: GENOMICS PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 529
SAUDI ARABIA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 530
SAUDI ARABIA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 531
SAUDI ARABIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 532
SAUDI ARABIA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 533
SAUDI ARABIA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 534
UNITED ARAB EMIRATES: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 535
UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 536
UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 537
UNITED ARAB EMIRATES: GENOMICS PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 538
UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 539
UNITED ARAB EMIRATES: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 540
UNITED ARAB EMIRATES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 541
UNITED ARAB EMIRATES: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 542
UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 543
REST OF GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 544
REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 545
REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 546
REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 547
REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 548
REST OF GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 549
REST OF GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 550
REST OF GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 551
REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 552
REST OF MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 553
REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 554
REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 555
REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 556
REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 557
REST OF MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 558
REST OF MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 559
REST OF MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 560
REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 561
AFRICA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 562
AFRICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 563
AFRICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 564
AFRICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 565
AFRICA: GENOMICS PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 566
AFRICA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 567
AFRICA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 568
AFRICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 569
AFRICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 570
AFRICA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 571
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN GENOMICS MARKET, JANUARY 2022−OCTOBER 2025
 
 
 
 
 
 
TABLE 572
GENOMICS PRODUCTS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 573
MARKET RANK OF KEY PLAYERS IN GENOMICS SERVICES MARKET (2024)
 
 
 
 
 
 
TABLE 574
GENOMICS MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 575
GENOMICS MARKET: PRODUCT FOOTPRINT
 
 
 
 
 
 
TABLE 576
GENOMICS MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 577
GENOMICS MARKET: TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
TABLE 578
GENOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 579
GENOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS
 
 
 
 
 
 
TABLE 580
GENOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2022—OCTOBER 2025
 
 
 
 
 
 
TABLE 581
GENOMICS MARKET: DEALS, JANUARY 2022—OCTOBER 2025
 
 
 
 
 
 
TABLE 582
GENOMICS MARKET: EXPANSIONS, JANUARY 2022—OCTOBER 2025
 
 
 
 
 
 
TABLE 583
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 584
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 585
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 586
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 587
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 588
ILLUMINA, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 589
ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 590
ILLUMINA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 591
ILLUMINA, INC.: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 592
ILLUMINA, INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 593
ILLUMINA, INC.: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 594
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 595
DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 596
DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 597
DANAHER CORPORATION: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 598
DANAHER CORPORATION: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 599
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 600
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 601
F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 602
F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 603
F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 604
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 605
AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 606
AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 607
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 608
AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 609
QIAGEN: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 610
QIAGEN: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 611
QIAGEN: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 612
QIAGEN: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 613
QIAGEN: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 614
REVVITY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 615
REVVITY: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 616
REVVITY: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 617
REVVITY: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 618
REVVITY: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 619
LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 620
LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED
 
 
 
 
 
 
TABLE 621
LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICE LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 622
LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 623
LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 624
IQVIA INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 625
IQVIA INC.: SERVICES OFFERED
 
 
 
 
 
 
TABLE 626
IQVIA INC.: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 627
CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 628
CHARLES RIVER LABORATORIES: SERVICES OFFERED
 
 
 
 
 
 
TABLE 629
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 630
BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 631
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 632
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 633
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 634
EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 635
EUROFINS SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 636
EUROFINS SCIENTIFIC: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 637
PACBIO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 638
PACBIO: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 639
PACBIO: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 640
PACBIO: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 641
PACBIO: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 642
PACBIO: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 643
OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 644
OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 645
OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 646
OXFORD NANOPORE TECHNOLOGIES PLC.: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 647
OXFORD NANOPORE TECHNOLOGIES PLC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 648
TAKARA BIO INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 649
TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 650
TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 651
TAKARA BIO INC.: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 652
BGI GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 653
BGI GROUP: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 654
BGI GROUP: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 655
BGI GROUP: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 656
BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 657
EPPENDORF SE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 658
EPPENDORF SE: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 659
EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 660
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 661
MERCK KGAA: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 662
MERCK KGAA: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 663
MERCK KGAA: EXPANSIONS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 664
BD: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 665
BD: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 666
BD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 667
BD: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 668
ABBOTT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 669
ABBOTT: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 670
10X GENOMICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 671
10X GENOMICS: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 672
10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 673
NEW ENGLAND BIOLABS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 674
NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 675
NEW ENGLAND BIOLABS: PRODUCT LAUNCHES, JANUARY 2021– SEPTEMBER 2024
 
 
 
 
 
 
TABLE 676
NEW ENGLAND BIOLABS: DEALS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 677
PROMEGA CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 678
PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 679
PROMEGA CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 680
PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025
 
 
 
 
 
 
TABLE 681
CREATIVE BIOGENE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 682
NOVOGENE CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 683
HELIX, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 684
PHALANX BIOTECH GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 685
POLARIS GENOMICS: COMPANY OVERVIEW
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
GENOMICS MARKET SEGMENTATION & REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 2
GENOMICS MARKET: YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 3
GENOMICS MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 4
GENOMICS MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
 
 
 
 
 
 
FIGURE 5
GLOBAL GENOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
 
 
 
 
 
 
FIGURE 6
GLOBAL GENOMICS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM–UP APPROACH), 2024
 
 
 
 
 
 
FIGURE 7
GENOMICS MARKET SIZE VALIDATION FROM INDUSTRY EXPERTS
 
 
 
 
 
 
FIGURE 8
SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 9
GENOMICS PRODUCTS MARKET, BY TECHNOLOGY (COMPANY REVENUE ANALYSIS)
 
 
 
 
 
 
FIGURE 10
GLOBAL GENOMICS MARKET: CAGR PROJECTIONS (2025–2030)
 
 
 
 
 
 
FIGURE 11
DATA TRIANGULATION
 
 
 
 
 
 
FIGURE 12
GENOMICS MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 13
GENOMICS PRODUCTS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 14
GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 15
GENOMICS PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 16
GENOMICS SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 17
GENOMICS SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 18
GENOMICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 19
GENOMICS MARKET, BY STUDY TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 20
REGIONAL SNAPSHOT OF GENOMICS MARKET
 
 
 
 
 
 
FIGURE 21
INCREASING GOVERNMENT FUNDING FOR GENOMICS PROJECTS TO PROPEL MARKET GROWTH
 
 
 
 
 
 
FIGURE 22
US AND DRUG DISCOVERY & DEVELOPMENT COMMANDED LARGEST MARKET SHARES IN 2024
 
 
 
 
 
 
FIGURE 23
CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
 
 
 
 
 
 
FIGURE 24
GENOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 25
BURDEN OF HIV INFECTIONS, BY REGION, 2024
 
 
 
 
 
 
FIGURE 26
GENOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 27
GROWTH OF GLOBAL GDP FROM 2020 TO 2024, WITH FORECASTS UNTIL 2030
 
 
 
 
 
 
FIGURE 28
GENOMICS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 29
GENOMICS MARKET ECOSYSTEM
 
 
 
 
 
 
FIGURE 30
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022–2024 (USD)
 
 
 
 
 
 
FIGURE 31
AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022–2024 (USD)
 
 
 
 
 
 
FIGURE 32
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022–2024 (USD)
 
 
 
 
 
 
FIGURE 33
REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN GENOMICS MARKET
 
 
 
 
 
 
FIGURE 34
PE/VC INVESTMENTS IN LIFE SCIENCES SPLIT BETWEEN PHARMACEUTICALS AND HEALTHCARE
 
 
 
 
 
 
FIGURE 35
TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014–2024
 
 
 
 
 
 
FIGURE 36
IMPACT OF AI/GEN AI ON GENOMICS MARKET
 
 
 
 
 
 
FIGURE 37
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
 
 
FIGURE 38
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
FIGURE 39
NORTH AMERICA: GENOMICS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 40
ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 41
REVENUE ANALYSIS OF KEY PLAYERS IN GENOMICS MARKET, 2020–2024 (USD BILLION)
 
 
 
 
 
 
FIGURE 42
MARKET SHARE ANALYSIS OF KEY PLAYERS IN GENOMICS PRODUCTS MARKET (2024)
 
 
 
 
 
 
FIGURE 43
GENOMICS MARKET: BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
FIGURE 44
GENOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
 
 
FIGURE 45
GENOMICS MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 46
GENOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
 
 
FIGURE 47
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 48
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 49
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 50
ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 51
DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 52
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 53
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 54
QIAGEN: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 55
REVVITY: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 56
LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 57
IQVIA INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 58
CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 59
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 60
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 61
PACBIO: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 62
OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 63
TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 64
EPPENDORF SE: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 65
MERCK KGAA: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 66
BD: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 67
ABBOTT: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 68
10X GENOMICS: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 

Methodology

This research study utilized extensive secondary sources, directories, and databases to identify and collect valuable information for analyzing the global genomics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to gather and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was primarily used to identify and collect information for the comprehensive, technical, market-oriented, and commercial study of the genomics market. The secondary sources used for this study include Nucleic Acids Research, Genome Biology, the International Journal of Genomics, the National Human Genome Research Institute (NHGRI), the International Chromosome and Genome Society (ICGS), Genome Canada, the European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, the Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), Nature Reviews Genetics, Nature Methods, the Biotechnology and Biological Sciences Research Council (BBSRC), the Organisation for Economic Co-operation and Development (OECD), Genome Research, the National Cancer Institute (NCI), the European Medicines Agency (EMA), the Population Health Research Institute (PHRI), PubMed, World Bank, the World Health Organization (WHO), Eurostat, and Factiva; research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also utilized to gather key information about major players, market classification, and segmentation, as well as industry trends, regional/country-level markets, market developments, and technological perspectives.

Primary Research

After acquiring foundational knowledge about the global genomics market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from academic & research institutes, hospitals, clinics & diagnostic labs, pharmaceutical & biopharmaceutical industries, CROs, and other end users. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

These interviews spanned six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

The following is a breakdown of the primary respondents:

Genomics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the genomics market. These methods were also used extensively to estimate the size of various market segments. The research methodology used to estimate the market size includes the following:

After determining the overall market size through the estimation process, the total market was divided into several segments and subsegments.

Genomics Market : Top-Down and Bottom-Up Approach

Genomics Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Genomics is a branch of molecular biology that involves the study of the structure, function, evolution, and mapping of genomes. It applies the techniques of genetics, molecular biology, and bioinformatics to sequence, assemble, and analyze the function and structure of the genome of a selected organism for analysis. Genomics is widely used in diagnostics, drug discovery and development, animal and agricultural research, forensics, and aquaculture research, among others.

Key Stakeholders

  • Genomics Equipment and Consumable Manufacturing Companies
  • Genomics Instrument/System Manufacturing Companies
  • Suppliers and Distributors of Genomic Instruments/Systems, Consumables, and Services
  • Hospitals, Diagnostic Centers, and Medical Colleges
  • Research Institutes
  • Hospitals and Academic Medical Centers (AMCs)
  • Government Bodies/Municipal Corporations
  • Business Research Firms
  • Venture Capitalists
  • Pharmaceutical and Biopharmaceutical Companies

Report Objectives

  • To define, describe, and forecast the genomics market based on offering, product type, service type, product by technology, application, end user by product, end user by service, and region, in terms of value
  • To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
  • To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall genomics market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key players in the genomics market and comprehensively analyze their product and service portfolios, market positions, and core competencies
  • To track and analyze competitive developments in the genomics market, such as acquisitions, product & service launches, expansions, agreements, partnerships, and collaborations
  • To benchmark players within the genomics market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product & service portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific genomics market into countries
  • A further breakdown of the Rest of Europe genomics market into countries
  • A further breakdown of the Rest of Latin America genomics market into countries
  • A further breakdown of the Rest of Middle East genomics market into countries

 

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Genomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Genomics Market

Nathan

Dec, 2022

I am looking for detailed market size valuation pointers for the Genomics Market from 2025 to 2030. Is this data included in your study?.

Andy

Dec, 2022

Can you elaborate more on the global growth dynamics of the Genomics Market?.

Edward

Oct, 2022

Which are the major building blocks for the global growth of Genomics Market?.

Lucas

Oct, 2022

Which of the geographical segment holds the major share of the Genomics Market?.

DMCA.com Protection Status